Home / Drug shortages / Lorlatinib Tablet

Lorlatinib Tablet — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Lorlatinib Tablet (tablet) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on 06/15/2026.

Shortage Details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0069-0227-03
Dosage Form
Tablet
Presentation
Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03)
Initial Posting
06/15/2026
Revised Date

FDA data resources